Abella Mar SRL
Abella Mar reported total assets of 150,376 € at the end of the 2025 financial year (annual accounts filed with the NBB on 26 Jun 2026).
The score of Abella Mar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +91 % Total assets +174 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Abella Mar's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 26 Jun 2026
- Year ended 31 Dec 2024filed on 16 Jun 2025
- Year ended 31 Dec 2023filed on 14 Jun 2024
- Year ended 31 Dec 2022filed on 21 Jun 2023
- Year ended 31 Dec 2021filed on 13 Jul 2022
Abella Mar's financial analysis
- Solvency55.8%sector median: 56.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Abella Mar
Abella Mar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0740.524.031
- VAT number
- BE0740524031
- Peppol
- Registered · 0208:0740524031 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 27 Dec 2019
- Registered office
- 2950 Kapellen
- Latest accounts
- 2025 · filed on 26 Jun 2026
- Activity
- Manufacture of basic pharmaceutical products (NACE 21100)
Abella Mar (SRL) has been based in Kapellen since 2019, active in: manufacture of basic pharmaceutical products. For 2025, it reports a net profit of 8,736 € and equity of 83,881 €; its revenue is not published. Its solvency stands at 55.8%, below the median of its sector (56.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Abella Mar
Companies in the same business, of comparable size and area, outside its group.
- Montefalcone Projects Manufacture of basic pharmaceutical products Maarkedal · balance sheet 207,746 €
- Sophie Delabie Manufacture of pharmaceutical preparations Willebroek · balance sheet 183,627 €
- Pharmacie Courouble Manufacture of basic pharmaceutical products Schaerbeek · balance sheet 129,672 €
- huMAN Manufacture of basic pharmaceutical products Gerpinnes · balance sheet 186,227 €
- L - Pharma Manufacture of pharmaceutical preparations Turnhout · balance sheet 10 €
- RTLC Manufacture of pharmaceutical preparations Brussels · balance sheet 107,167 €
- Yaro Preclinical Consulting Manufacture of basic pharmaceutical products Turnhout · balance sheet 158,481 €
- BelCoPhar Manufacture of pharmaceutical preparations Kalmthout · balance sheet 224,468 €
Frequently asked questions about Abella Mar
What is the revenue of Abella Mar?
Abella Mar files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Abella Mar?
In Belgium, the VAT number is the company number prefixed with BE: BE0740524031 for Abella Mar, if the company is VAT-registered. Its company number (CBE) is 0740.524.031.
Where is the registered office of Abella Mar?
According to the CBE register, the registered office of Abella Mar is in 2950 Kapellen.
What is the equity of Abella Mar?
At the close of the 2025 financial year, the equity of Abella Mar amounts to 83,881 €, a solvency of 55.8% of total assets.
Who manages Abella Mar?
The register lists 1 active mandates at Abella Mar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Abella Mar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →